Creating a new way to treat peanut allergies using microneedles
Official title: Scale-up manufacturing of microneedle stamp for peanut allergen immunotherapy
Funded at Moonlight Therapeutics, INC. · NIH-11084470 · Data updated 2026-11-12
This study is testing a new way to help kids with peanut allergies feel safer by using tiny microneedles to deliver peanut allergens into their skin, which could help them build up a tolerance and reduce the chances of serious allergic reactions.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Moonlight Therapeutics, INC. NIH-funded |
| Lab location | 1 site (Marietta, UNITED STATES) |
| Project start | May 6, 2024 |
| Project end | April 30, 2027 |
| Funding year | 2025 |
| Award (this year) | $997,668 |
| NIH project number | 5SB1AI184000-02 |
| Project ID | NIH-11084470 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are children aged 0-11 years who have a diagnosed peanut allergy.
✕Less likely to help
Patients who do not have a peanut allergy or are older than 11 years may not benefit from this research.
What this research studies
This research focuses on developing a microneedle stamp that can deliver peanut allergens into the skin to help desensitize children with peanut allergies. The approach aims to provide a targeted and efficient method for immunotherapy, which could significantly reduce the risk of severe allergic reactions. By using microneedles that penetrate only the top layers of skin, the treatment is designed to be quick and minimally invasive. The goal is to improve the quality of life for children with peanut allergies and provide peace of mind for their families.
Why it matters
Potential benefit: If successful, this research could lead to a new, effective treatment for peanut allergies, reducing the risk of life-threatening reactions.
How similar studies have gone: Other research has shown promise in using microneedle technology for allergen immunotherapy, indicating potential for success in this approach.
Where this research is happening
-
Moonlight Therapeutics, INC.
Marietta, United States Active
Researchers
- Principal investigator: Patel, Samirkumar — Moonlight Therapeutics, INC.
- Study coordinator: Patel, Samirkumar
Related research
Other NIH-funded projects on the same topics.
-
Boosting immune response to fight cancer
This study is exploring a new way to help your immune system better fight cancer by tweaking certain cells in your body, and it aims to improve treatment for people with advanced cancer.
-
A center focused on immunotherapy for pediatric cancers.
This study is exploring new ways to use the body's immune system to fight childhood cancers, aiming to create better treatments for kids whose cancers haven't responded well to standard therapies.
-
Algorithms to find HLA-E neoantigens for cancer immunotherapy
Aims to develop computer methods to discover tumor-specific targets presented by HLA-E to guide new T cell therapies for cancer.
-
Immunotherapy for glioblastoma: advancing treatment and understanding
A patient-friendly summary of a grant exploring new immune-based treatments for glioblastoma to improve options for people affected by this brain cancer.
-
How CRISPR-based gene activation could shape immunotherapy responses in clear cell cancers
A research project at Stanford is using CRISPR-based gene activation to understand why some clear cell ovarian and kidney cancers respond to immunotherapy while others do not.
-
Hybrid biomaterial system to boost immunotherapy for rheumatoid arthritis
A new, patient-facing immunotherapy approach uses specialized particles to retrain the immune system to calm RA in adults.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.